SBCCP - Sociedade Brasileira de Cirurgia de Cabeça e Pescoço

PRELIMINARY PROGRAMME

Thursday, 8 May
08.30 -13.00 - LIVE SURGERY
                          Minimally invasive surgery (thyroid gland,                           larynx, pituarity gland, ESS, salivary gland)                                       (ERBE, Storz, Medtronic, Olympus,                           Omni-Guide)
                          Instructional Videopresentations                                          Workshops (sialoendoscopy – Storz)
13.00 -14.30 - Lunch
14.30 -15.30 - Genzyme Satelite Symposium: Thyroid                     Cancer Management
15.45-16.45 - IRX Satelite Symposium: IRX-2: Advancing                     the Role of Immunotherapy in Head and                     Neck Cancer
17.00-18.30 - Merck Satelite Symposium: ERBITUX –                     Evolving Treatment Standard in Head and                     Neck Cancer
19.00                Opening Ceremony
19.30                Welcome Reception (Sponsored by Merck)

Friday, 9 May
08.30 – 10.30 - Free topics
11.00 – 13.00 - Cutaneous malignancies
13.00 – 14.00 - Lunch
14.00 – 16.00 - Management of Persistent Disease
16.30 – 18.30 - General Assembly of EHNS
20.30 Conference dinner

Saturday, 10 May
08.30 – 10.30 - Free topics
11.00 – 13.00 - Salivary Gland Tumours
13.00 – 14.00 - Lunch
14.00 – 16.00 - Management of Complications of Combined Treatment
16.30 – 18.30 - Free topics
18.30 Closing Ceremony

FREE TOPICS
Targeted therapy
Reconstruction after major head and neck surgery
Head and neck cancer in the elderly
Oropharyngeal cancer – treatment modalities and outcome
QOL following treatment of head and neck cancer
The role of laser surgery in laryngopharyngeal cancer
The relevance of second primaries
Status of sentinel node biopsies in head and neck tumours
The role of PET – scanning in head and neck tumours
Thyroid cancer

MAIN TOPICS
Cutaneous malignancies     Management of Persistent                                             Disease
Chair: M. Virag (CRO)            Chair: Remco de Bree (N)
Co-Chair: A.M. Shenoy (In)     Co-chair: L. Licitra (I)
Keynote Lecture: H. de Wilt    Keynote Lecture: P. Nicolai
(NL)                                      (I)
6 Proffered Papers + 3PP        6 Proffered Papers + 3 PP
Conclusion Remarks:              Conclusion Remarks:
J. Werner (G)                          R. Knecht (G)

Salivary Gland Tumours      Management of                                             Complications of                                             Combined Treatment
Chair: H. Iro (G)                      Chair: G. Spriano (I)
Co-chair: A. Skalova (Cz)        Co-chair: A.D. Rapidis (Gr)
Keynote Lecture: P. Bradley    Keynote Lecture: J.P. (UK)                                      Shah (USA)
6 Proffered Papers + 3 PP       6 Proffered Papers + 3 PP
Conclusion Remarks: M.         Conclusion Remarks: J.B.
Julieron (F)                             Vermorken (B)

Special Invited Lecture
Luka Milas (USA): “Molecular targeting in radio(chemo) therapy of head and neck cancer: anti – EGFR approach and beyond”.